60 DEGREES PHARMACEUTICALS, INC. - Annual Financials - Cash Flow (SEC)

Updated on January 3, 2026.

Related Topics: SEC Topic List.

Data Source: SEC.

See details in table below.

You can see similar for other companies.

60 DEGREES PHARMACEUTICALS, INC. - Annual Cash Flow (In Thousands of USD, Except Per Share Amounts)

Breakdown	2024-12-31	2023-12-31	2022-12-31
Net Loss	0	-48.098
Depreciation	11.726	21.162
Amortization	38.502	29.157
Amortization of Debt Discount	0	669.148
Amortization of ROU Asset	13.517	50.053
Amortization of Note Issuance Costs	0	67.728
Amortization of Capitalized Share-Based Payments	3575.881	994.643
Share-Based Compensation to Vendors for Services	0	212.605
Share-Based Compensation under Equity Incentive Plan	32.767	528.926
Deemed Capital Contribution for Related Party Compensation Expense (Note 10)		163.228
Loss on Debt Extinguishment	0	-1231.48
Change in Fair Value of Derivative Liabilities	1665.966	-37.278
Derivative Expense	0	-399.725
Change in Fair Value of Promissory Note	0	5379.269
Write-offs of Capitalized Patents	108.424	0
Inventory Reserve	0	-160.338
Accounts Receivable	255.416	185.367
Prepaid and Other Assets	39.423	522.37
Inventory	-23.405	-212.747
Accounts Payable and Accrued Liabilities	501.412	-214.734
Accrued Interest, net	23.604	-1265.361
Reduction of Lease Liability	-13.65	-50.273
Deferred Compensation	0	-100
Net Cash Used in Operating Activities	-5648.088	-4542.91
Capitalization of Patents	51.967	39.982
Purchases of Fixed Assets	103.773	57.623
Acquisition of Intangibles	25.374	18.283
Purchase of Short-Term Investments	1708	0
Net Cash Used in Investing Activities	-1889.114	-115.888
Net Proceeds from January 2024 Offering	1898.296	0
Proceeds from IPO and Over-Allotment, net of underwriting discounts, commissions, and deferred offering costs paid in 2023 of $1,198,111	0	6303.905
Proceeds from ATM Offering, net of offering costs paid at closing and deferred offering costs of $264,774	1729.81	0
Proceeds from Private Placement, net of offering costs paid at closing and deferred offering costs of $582,600	3414.502	0
Proceeds from Exercise of Warrants	0	1131.771
Proceeds from Exercise of Pre-Funded Warrants	10.963	0
Proceeds from Notes Payable	0	650
Repayment of Notes Payable	0	1611.111
Proceeds from Advances - Related Party	0	250
Repayment of Related Party Advances	0	250
Net Cash Provided by Financing Activities	7053.571	6474.565
Effect of Exchange Rate Changes on Cash	0.499	61.853
Change in Cash and Cash Equivalents	-483.132	1877.62
Cash and Cash EquivalentsBeginning of Period	1659.353	2142.485	264.865
Cash and Cash EquivalentsEnd of Period	1659.353	2142.485	264.865
Cash paid During the Year for Interest	8.772	179.117
Cash paid During the Year for Income Taxes	2	1
Conversion of Debt into Common Stock	0	7989.598
Conversion of Debt into Series A Preferred Stock	0	10128.5
Conversion of Series A Preferred Stock into Common Stock	290.601	270.46
Capitalized Share-Based Payments to Vendors	26.325	4916.555
Fair Value of Warrants Issued to Underwriters	71.364	301.416
Reclassification of Liability-classified Warrants to Equity-classified	0	0
Additions to ROU Assets for Lease Renewal	0	50.922
Additions to Lease Liabilities for Lease Renewal	0	50.57
Debt Discount Recorded in Connection with Derivative Liabilities	0	650
Stock Issued for Payment of Deferred Compensation	0	520
Stock Issued for Acquisition of Intangibles	0	33.895
Net of underwriting discounts and commissions paid at closing	1198.111	1198.111
ATM Offering, net of offering costs paid	264.774	264.774
Private Placement, net of offering costs	582.6	582.6